First Vietnamese high-achieving athletes receive Covid-19 vaccine
	First COVAX's vaccine shipment to reach Vietnam in early April
	Quarantine waiver approved for tourists travelling to Phuket in Thailand

Talking to VnExpress on March 30 afternoon, Associate Professor, Dr. Vu Dinh Them, Director of the Center for Clinical Trials under the National Institute of Hygiene and Epidemiology said that after administration, volunteers are in stable health conditions. Some people experience mild reactions such as pain at the injection site, headache, muscle pain, fatigue within one day.

On two days of March 31 and April 2, the other 30 volunteers are expected to receive the Covivac vaccine.

A volunteer receives the Covivac vaccine. Photo: Vnexpress

Covivac, produced by the Institute of Vaccines and Medical Biologicals (IVAC), entered its first phase of the human trials in late January. A total of 120 volunteers participate in the clinical trial. They are randomly injected with the vaccine or placebo. After inoculation, volunteers are required to stay at the vaccination site for 24 hours for further health monitoring.

Each volunteer is given two shots, each 28 days apart.

Volunteers will receive health checks eight days after the injections, with researchers monitoring them over the phone and doing further checks throughout the trials to evaluate the vaccine’s immunogenicity.

The mid-term report of the first phase is expected to be completed in July.

Nguyen Ngo Quang, Deputy Head of the Ministry of Health’s Administration of Science Technology and Training, said the total insurance cover for the volunteers is around VND 40 billion ($1.7 million).

Through pre-clinical assessments conducted in India, the U.S, and Vietnam, the Covivac vaccine has recorded a strong immunological effect on laboratory animals and has so far proved to be safe.

Photo: VTC News

The Covivac vaccine was also proved to be effective against the new SARS-CoV strain detected in both the UK and South Africa.

The IVAC plans to offer the Covivac vaccine at a price of VND 60,000 ($2.6) per dose.

Meanwhile, the first made-in-Vietnam Covid-19 vaccine Nanocovax by Nanogen Pharmaceutical Biotechnology JSC entered its second phase of human trials with the participation of 560 volunteers including more than 100 people over 60 years old in Hanoi and Long An’s Ben Luc District.

Associate Professor, Dr. Chu Van Men, Director of the Center for Clinical Trial and Bioequivalence under the Vietnam Military Medical University said 90 people in Hanoi and more than 100 people in Long An received the second dose. The injections are expected to be completed on April 6.

Volunteers receiving the second shot are in stable health condition. Several people display reactions such as mild fever, muscle pain and pain at the injection site. Doctors are closely monitoring their health.

Vietnam has two other COVID-19 candidate vaccines being developed, which are VABIOTECH by the Company for Vaccine and Biological Production No 1, and POLYVAC by the Centre for Research and Production of Vaccines and Biologicals.

Vietnam plans for application of ‘vaccine passport’ The Ministry of Health is detailing a plan on the regime, location, isolation time, medical testing and monitoring for COVID-19 vaccine passport holders.

EU applied tough rules on vaccine exports, putting more pressures on AstraZeneca Strict rules on vaccine exports have been applied by The European Union, and also put more pressure on AstraZeneca to deliver more shots to the ...

Deputy PM gets second shot of homegrown COVID-19 vaccine Deputy Prime Minister Vu Duc Dam on March 26 received the second shot of made-in-Vietnam NanoCovax vaccine, which is on the second trial phase.